Biostem Investor Relations Material

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing and producing alternative products to treat ailments such as joint pain, tendon and ligament injuries, neurodegenerative diseases, autoimmune disease and other illnesses. The company is also engages in repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compound supplies; nutraceuticals; e-commerce platforms; and development of non-proprietary products such as Dr. Dave’s Best and Nesvik Organics brands of supplements and other non-proprietary products in the United States and internationally.